In a preceding analysis of 63 specimens from patients with MPN in the blast phase, ASXL1 mutations were detected in paired specimens during both chronic and blast phase MPN, thereby implicating ASXL1 mutations in leukemic transformation, while TET2 mutations were frequently acquired during leukemic transformation [27]. This evidence concerns the gene TET2 and myeloproliferative disorder.